Shanu Modi, MD
Enriched profileBreast Medical Oncologist / Assistant Attending, Breast Medicine Service; Section Head, HER2 Positive Breast Cancer · Memorial Sloan Kettering Cancer Center
Shanu Modi is Breast Medical Oncologist / Assistant Attending, Breast Medicine Service; Section Head, HER2 Positive Breast Cancer at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 425 publications with 20,413 citations (h-index 61); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 16 Oct 2026
Shanu Modi, MD, is Breast Medical Oncologist / Assistant Attending, Breast Medicine Service at Memorial Sloan Kettering Cancer Center. The public record shows 425 publications with 20,413 citations (h-index 61), centered on HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 18 companies.
- Most recent indexed publication: 2026 · Cancer discovery
- Top research focus: HER2/EGFR in Cancer Research
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 159.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
- T-Cell Therapy for Advanced Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
- Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 16 Oct 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- WHITEHALL INTERNATIONAL INCProgram year20252 payments$14,459openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20254 payments
- Daiichi Sankyo Company LTDProgram year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Aromatase Inhibitor58.5%Anastrozole57%Letrozole31%Exemestane12%Part D<11 patientsKinase inhibitor20.9%Ibrance40%Verzenio33%Kisqali27%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 16 Oct 2026
144 congress contributions (2006–2026) across AACR, ASCO, ESMO, SABCS per OpenAlex. The most recent:
- Tumor evolution following treatment with sacituzumab govitecan for metastatic breast cancer: A proteomic analysis.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.
Cancer discovery
Article2026 - Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort study.
Breast cancer research and treatment
Article2025 - Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.
Nature reviews. Clinical oncology
Erratum2024
Most-cited works
by citation count (OpenAlex)- 01Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer2,574 citations2022
- 02Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer1,982 citations2019
- 03Unlocking the potential of antibody–drug conjugates for cancer therapy1,098 citations2021
- 04The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers1,015 citations2018
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/shanu-modi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Shanu-Modi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/memorial-sloan-kettering-cancer-center_cancerstraighttalk-activity-6975558885621260288-Z6TD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/memorial-sloan-kettering-cancer-center_dr-shanu-modi-a-breast-medical-oncologist-activity-7390055263455838209-f6dB
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
mskcc.org/cancer-care/doctors/shanu-modi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - X / Twitter
x.com/MSKCancerCenter/status/1533533014004797445
- YouTube
mskcc.org/podcasts/cancer-straight-talk/game-changing-cancer-drug-gives-stage-4-breast-cancer-patients-new
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - LinkedIn
Featured in Memorial Sloan Kettering Cancer Center LinkedIn post highlighting her work as a breast medical oncologist
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- Internal Medicine residency
University of Alberta
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Medical Oncology subspecialty training
Cross Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board Certified
Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
- Section Head
HER2 Positive Breast Cancer, Breast Medicine Service, MSKCC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mskcc.org ↗
- 2009 Advanced Clinical Research Award (ACRA) in Breast Cancer
Breast Cancer Research Foundation/Conquer Cancer Foundation
2009provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connection.asco.org ↗
Secondary affiliations
appointments beyond the home institution- Professor of Medicine (rank varies across sources: Associate/full Professor)
Weill Cornell Medical College / Weill Cornell Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vivo.weill.cornell.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- Podcast interview
"How to Get a Standing Ovation at ASCO?" - Our MBC Life
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ourmbclife.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curetoday.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Hope Rugo, MD
City of Hope
Dennis Slamon, MD
University of California, Los Angeles